Prostate Cancer

Prostate cancer specialists outline the pros and cons of the rectal spacer options for patients with prostate cancer and discuss factors that influence spacer choice.

The expert panel outlines visibility considerations with the 3 rectal spacer options when treating patients with prostate cancer with radiation therapy.

The open-label CaRe PC trial plans to enroll up to 30 adult patients with mCRPC, who will be treated across 3 dose levels of INKmune.

"Nowadays, the complexity of potential management options have gotten increasingly difficult to express to patients," says Andrew L. Siegel, MD.

Over a decade of data document a continued increase in the use of hypofractionation in patients with localized prostate cancer.

Over the past year, the FDA approved a multitude of new treatments and devices for use in urology practice.

Jeffrey T. Schiff, MD, MPH, describes PEG hydrogel spacers and discusses their role in treating patients with prostate cancer undergoing radiation therapy.

Rizwan Nurani, MD, an expert on prostate cancer, describes the role of balloon spacers in the treatment space.

“I believe that at this point in time, we should be able to offer our patients some options, to at least give them a sense of feeling that they're participating in this procedure, that they have some control over this procedure. I think nitrous oxide can provide that,” says Heidi J. Rayala, MD, PhD.

As the year comes to a close, we revisit some of this year’s top content on prostate cancer.

"I think that what most people will find is, if you're in an academic center, it can be a little bit difficult to set up a nitrous oxide program because there is a lot of red tape for bringing a gas into the ambulatory setting," says Heidi J. Rayala, MD, PhD.

"This study, using a novel technology to manage hot flashes, truly moves the field forward in improving the quality of life for men with prostate cancer,” says Alicia K. Morgans, MD, MPH.

Investigators analyzed data from over 1300 patients undergoing treatment for prostate cancer at 5 hospitals.

Following a review of rectal spacer options, Varun Sundaram, MD, offers clinical perspectives on hyaluronic acid spacers for patients with prostate cancer undergoing radiation.

Clinical insights on challenges and complications of rectal spacing encountered in the treatment of patients with prostate cancer.

With multiple PSMA PET tracers available, Jaideep S. Sohi, MD, shares insights about the benefits of the various options and his real-world experience with their use in practice.

A prostate imaging expert shares tips for how to interpret PSMA PET/CT imaging results as well as when re-imaging is recommended.

A response by the FDA is expected by February 2024.

Jaideep S. Sohi, MD, discusses how PSMA PET imaging has impacted diagnosis and management of prostate cancer in clinical practice, when and why it should be considered over conventional imaging, and which PSMA PET tracers are available.

Christopher M. Pieczonka, MD and Jose De La Cerda, MD, MPH share their expertise in managing metastatic castration-resistant prostate cancer (mCRPC), focusing on the demographics in their distinct clinical practices and unique challenges they encounter nuances of treatment.  

Eric J. Small, MD, is an international leader in prostate cancer research and has published more than 430 peer-reviewed articles.

“I think if you were to ask what surprised me, I didn't expect it to have more of an effect on pain than anxiety,” says Heidi J. Rayala, MD, PhD.

Specialists in the field of prostate cancer discuss their approaches for discussing rectal spacing with patients.

Comprehensive insights on the utilization of rectal spacers with proton beam radiation and brachytherapy in prostate cancer.

In this episode, David M. Albala, MD, and Sanoj Punnen, MD, discuss precision medicine and the use of biomarker tests in prostate cancer screening and detection.